Market Research Logo

Global Liposome Drug Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Global Liposome Drug Delivery Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

Scope of the Report:
This report focuses on the Liposome Drug Delivery in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang
CSPC
Novartis
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Liposomal Bupivacaine
Other Liposomals

Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

There are 15 Chapters to deeply display the global Liposome Drug Delivery market.

Chapter 1, to describe Liposome Drug Delivery Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Liposome Drug Delivery, with sales, revenue, and price of Liposome Drug Delivery, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Liposome Drug Delivery, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Liposome Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Liposome Drug Delivery sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Liposome Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Liposomal Doxorubicin
1.2.2 Liposomal Amphoteracin B
1.2.3 Liposomal Paclitaxel
1.2.4 Liposomal Bupivacaine
1.2.5 Other Liposomals
1.3 Market Analysis by Applications
1.3.1 Fungal Infection Therapy
1.3.2 Cancer & Tumor Therapy
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Liposome Drug Delivery Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead Sciences
2.2.1 Business Overview
2.2.2 Liposome Drug Delivery Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pacira
2.3.1 Business Overview
2.3.2 Liposome Drug Delivery Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Pacira Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Liposome Drug Delivery Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Liposome Drug Delivery Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma-Tau Group
2.6.1 Business Overview
2.6.2 Liposome Drug Delivery Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Sigma-Tau Group Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva Pharmaceutical
2.7.1 Business Overview
2.7.2 Liposome Drug Delivery Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ipsen (Onivyde)
2.8.1 Business Overview
2.8.2 Liposome Drug Delivery Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Fudan-Zhangjiang
2.9.1 Business Overview
2.9.2 Liposome Drug Delivery Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CSPC
2.10.1 Business Overview
2.10.2 Liposome Drug Delivery Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CSPC Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Liposome Drug Delivery Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Novartis Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kingond Pharm
2.12.1 Business Overview
2.12.2 Liposome Drug Delivery Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Kingond Pharm Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Shanghai New Asia
2.13.1 Business Overview
2.13.2 Liposome Drug Delivery Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Shanghai New Asia Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Spectrum Pharmaceuticals
2.14.1 Business Overview
2.14.2 Liposome Drug Delivery Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Spectrum Pharmaceuticals Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Liposome Drug Delivery Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Liposome Drug Delivery Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Liposome Drug Delivery Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Liposome Drug Delivery Manufacturer Market Share
3.3.2 Top 6 Liposome Drug Delivery Manufacturer Market Share
3.4 Market Competition Trend
4 Global Liposome Drug Delivery Market Analysis by Regions
4.1 Global Liposome Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Liposome Drug Delivery Sales and Market Share by Regions (2013-2018)
4.1.2 Global Liposome Drug Delivery Revenue and Market Share by Regions (2013-2018)
4.2 North America Liposome Drug Delivery Sales and Growth Rate (2013-2018)
4.3 Europe Liposome Drug Delivery Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Liposome Drug Delivery Sales and Growth Rate (2013-2018)
4.5 South America Liposome Drug Delivery Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Liposome Drug Delivery Sales and Growth Rate (2013-2018)
5 North America Liposome Drug Delivery by Countries
5.1 North America Liposome Drug Delivery Sales, Revenue and Market Share by Countries
5.1.1 North America Liposome Drug Delivery Sales and Market Share by Countries (2013-2018)
5.1.2 North America Liposome Drug Delivery Revenue and Market Share by Countries (2013-2018)
5.2 United States Liposome Drug Delivery Sales and Growth Rate (2013-2018)
5.3 Canada Liposome Drug Delivery Sales and Growth Rate (2013-2018)
5.4 Mexico Liposome Drug Delivery Sales and Growth Rate (2013-2018)
6 Europe Liposome Drug Delivery by Countries
6.1 Europe Liposome Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 Europe Liposome Drug Delivery Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Liposome Drug Delivery Revenue and Market Share by Countries (2013-2018)
6.2 Germany Liposome Drug Delivery Sales and Growth Rate (2013-2018)
6.3 UK Liposome Drug Delivery Sales and Growth Rate (2013-2018)
6.4 France Liposome Drug Delivery Sales and Growth Rate (2013-2018)
6.5 Russia Liposome Drug Delivery Sales and Growth Rate (2013-2018)
6.6 Italy Liposome Drug Delivery Sales and Growth Rate (2013-2018)
7 Asia-Pacific Liposome Drug Delivery by Countries
7.1 Asia-Pacific Liposome Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Liposome Drug Delivery Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Liposome Drug Delivery Revenue and Market Share by Countries (2013-2018)
7.2 China Liposome Drug Delivery Sales and Growth Rate (2013-2018)
7.3 Japan Liposome Drug Delivery Sales and Growth Rate (2013-2018)
7.4 Korea Liposome Drug Delivery Sales and Growth Rate (2013-2018)
7.5 India Liposome Drug Delivery Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Liposome Drug Delivery Sales and Growth Rate (2013-2018)
8 South America Liposome Drug Delivery by Countries
8.1 South America Liposome Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 South America Liposome Drug Delivery Sales and Market Share by Countries (2013-2018)
8.1.2 South America Liposome Drug Delivery Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Liposome Drug Delivery Sales and Growth Rate (2013-2018)
8.3 Argentina Liposome Drug Delivery Sales and Growth Rate (2013-2018)
8.4 Colombia Liposome Drug Delivery Sales and Growth Rate (2013-2018)
9 Middle East and Africa Liposome Drug Delivery by Countries
9.1 Middle East and Africa Liposome Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Liposome Drug Delivery Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Liposome Drug Delivery Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Liposome Drug Delivery Sales and Growth Rate (2013-2018)
9.3 UAE Liposome Drug Delivery Sales and Growth Rate (2013-2018)
9.4 Egypt Liposome Drug Delivery Sales and Growth Rate (2013-2018)
9.5 Nigeria Liposome Drug Delivery Sales and Growth Rate (2013-2018)
9.6 South Africa Liposome Drug Delivery Sales and Growth Rate (2013-2018)
10 Global Liposome Drug Delivery Market Segment by Type
10.1 Global Liposome Drug Delivery Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Liposome Drug Delivery Sales and Market Share by Type (2013-2018)
10.1.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Liposomal Doxorubicin Sales Growth and Price
10.2.1 Global Liposomal Doxorubicin Sales Growth (2013-2018)
10.2.2 Global Liposomal Doxorubicin Price (2013-2018)
10.3 Liposomal Amphoteracin B Sales Growth and Price
10.3.1 Global Liposomal Amphoteracin B Sales Growth (2013-2018)
10.3.2 Global Liposomal Amphoteracin B Price (2013-2018)
10.4 Liposomal Paclitaxel Sales Growth and Price
10.4.1 Global Liposomal Paclitaxel Sales Growth (2013-2018)
10.4.2 Global Liposomal Paclitaxel Price (2013-2018)
10.5 Liposomal Bupivacaine Sales Growth and Price
10.5.1 Global Liposomal Bupivacaine Sales Growth (2013-2018)
10.5.2 Global Liposomal Bupivacaine Price (2013-2018)
10.6 Other Liposomals Sales Growth and Price
10.6.1 Global Other Liposomals Sales Growth (2013-2018)
10.6.2 Global Other Liposomals Price (2013-2018)
11 Global Liposome Drug Delivery Market Segment by Application
11.1 Global Liposome Drug Delivery Sales Market Share by Application (2013-2018)
11.2 Fungal Infection Therapy Sales Growth (2013-2018)
11.3 Cancer & Tumor Therapy Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Liposome Drug Delivery Market Forecast (2018-2023)
12.1 Global Liposome Drug Delivery Sales, Revenue and Growth Rate (2018-2023)
12.2 Liposome Drug Delivery Market Forecast by Regions (2018-2023)
12.2.1 North America Liposome Drug Delivery Market Forecast (2018-2023)
12.2.2 Europe Liposome Drug Delivery Market Forecast (2018-2023)
12.2.3 Asia-Pacific Liposome Drug Delivery Market Forecast (2018-2023)
12.2.4 South America Liposome Drug Delivery Market Forecast (2018-2023)
12.2.5 Middle East and Africa Liposome Drug Delivery Market Forecast (2018-2023)
12.3 Liposome Drug Delivery Market Forecast by Type (2018-2023)
12.3.1 Global Liposome Drug Delivery Sales Forecast by Type (2018-2023)
12.3.2 Global Liposome Drug Delivery Market Share Forecast by Type (2018-2023)
12.4 Liposome Drug Delivery Market Forecast by Application (2018-2023)
12.4.1 Global Liposome Drug Delivery Sales Forecast by Application (2018-2023)
12.4.2 Global Liposome Drug Delivery Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report